King Cheung

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Novavax (United States)(Current)

Griffith University

The University of Queensland

UNSW Sydney

King Cheung is an author at Novavax (United States) specializing in infectious diseases, veterinary medicine, and booster response to protein subunit vaccines.

Publications per year

2023–2024

Publications

Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial

Chijioke Bennett, Wayne Woo, Mark Bloch et al. · The Lancet Infectious Diseases · 2024 · 19 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial

Chijioke Bennett, Elizabeth Rivers, Wayne Woo et al. · The Journal of Infectious Diseases · 2023 · 11 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–2 of 2